Ardent Health Partners (NYSE:ARDT) Price Target Raised to $25.00

Ardent Health Partners (NYSE:ARDT) had its price target raised by Leerink Partners from $23.00 to $25.00 in a research report report published on Tuesday morning,Benzinga reports. Leerink Partners currently has an outperform rating on the stock.

Several other research firms have also recently commented on ARDT. KeyCorp assumed coverage on shares of Ardent Health Partners in a report on Friday, October 11th. They set an “overweight” rating and a $24.00 price target for the company. Stephens restated an “overweight” rating and set a $24.00 price target on shares of Ardent Health Partners in a report on Thursday, September 19th. JPMorgan Chase & Co. assumed coverage on shares of Ardent Health Partners in a report on Monday, August 12th. They set a “neutral” rating and a $18.00 price target for the company. Mizuho began coverage on shares of Ardent Health Partners in a report on Monday, August 12th. They set an “outperform” rating and a $20.00 price target for the company. Finally, Morgan Stanley began coverage on shares of Ardent Health Partners in a research note on Monday, August 12th. They issued an “overweight” rating and a $27.00 target price for the company. Two equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, Ardent Health Partners currently has a consensus rating of “Buy” and a consensus price target of $21.82.

Ardent Health Partners Trading Down 6.9 %

Shares of ARDT opened at $16.59 on Tuesday. Ardent Health Partners has a one year low of $14.57 and a one year high of $20.72. The stock has a 50-day moving average price of $18.18. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78.

Ardent Health Partners (NYSE:ARDT) last posted its quarterly earnings results on Wednesday, August 14th. The company reported $0.35 EPS for the quarter, topping the consensus estimate of $0.30 by $0.05. The company had revenue of $1.47 billion for the quarter, compared to analyst estimates of $1.46 billion. Equities analysts forecast that Ardent Health Partners will post 1.25 EPS for the current year.

Hedge Funds Weigh In On Ardent Health Partners

A number of institutional investors have recently modified their holdings of the company. Wellington Management Group LLP bought a new position in shares of Ardent Health Partners in the third quarter valued at approximately $28,724,000. Point72 Asset Management L.P. bought a new position in shares of Ardent Health Partners in the third quarter valued at approximately $27,428,000. Goldentree Asset Management LP bought a new position in shares of Ardent Health Partners in the third quarter valued at approximately $22,897,000. Allspring Global Investments Holdings LLC bought a new position in shares of Ardent Health Partners in the third quarter valued at approximately $13,119,000. Finally, Soros Fund Management LLC bought a new position in shares of Ardent Health Partners in the third quarter valued at approximately $4,595,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.